US2023181312A1PendingUtilityA1

Prosthetic capsular devices, systems, and methods

Assignee: OMEGA OPHTHALMICS LLCPriority: Jun 19, 2014Filed: Dec 14, 2022Published: Jun 15, 2023
Est. expiryJun 19, 2034(~7.9 yrs left)· nominal 20-yr term from priority
A61F 2/1624A61F 9/00736A61F 2/1648A61F 2/1694A61B 34/25A61F 2/1618A61F 2002/1681A61F 2250/0002A61F 2/14A61F 2/15A61F 2002/16901A61F 2/1659A61B 90/04A61F 2/1662
79
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Prosthetic capsular devices (e.g., bag, bowl, housing, structure, cage, frame) include technology devices such as a computer, virtual reality device, display device, WiFi/internet access device, image receiving device, biometric sensor device, game device, image viewers or senders, GPSs, e-mail devices, combinations thereof, and/or the like. The technology devices can be used in combination with an intraocular lens. The output from the technology device(s) can be fed to the retina of the user to provide a visual image, can be otherwise connected to the user, and/or can be used to control the properties of the intraocular lens or of the prosthetic capsular device. Wearable technology that provides biometric data, such as blood glucose levels, body temperature, electrolyte balance, heart rate, EKG, EEG, intraocular pressure, sensing ciliary muscle contraction for accommodation stimulus, dynamic pupil change and retinal prostheses, combinations thereof, and the like can assist in technology-assisted health care functions.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A prosthetic capsular device configured to be inserted in a natural capsular bag of an eye after removal of a lens, the device comprising:
 a housing structure having a discoid shape configured to contain one or more intraocular lenses or technology devices, the housing structure comprising:
 a longitudinal axis; 
 a posterior side; 
 an anterior side opposite the posterior side, the anterior side comprising an anterior opening; 
 a continuous lateral side extending between the posterior side and the anterior side, the continuous lateral side comprising one or more protrusions projecting therefrom; 
 a cavity at least partially defined by the posterior side, the anterior side, and the continuous lateral side, wherein the cavity is configured to contain the one or more intraocular lenses or technology devices, and wherein the anterior opening is configured to allow insertion of the one or more intraocular lenses or technology devices into the cavity of the housing structure through the anterior opening; and 
 an exterior surface of the housing structure comprising a middle portion, wherein the exterior surface of the housing structure tapers radially inward from the middle portion to the anterior opening; and 
   a slow release fully or partially dissolvable pharmaceutical agent or a non-dissolvable prostheses coated with a slow release pharmaceutical agent for introduction into the eye, wherein the slow release fully or partially dissolvable pharmaceutical agent or non-dissolvable prostheses is located within the housing structure outside a visual axis of the eye.   
     
     
         3 . The prosthetic capsular device of  claim 2 , wherein the continuous lateral side comprises one protrusion. 
     
     
         4 . The prosthetic capsular device of  claim 2 , wherein the continuous lateral side comprises more than one protrusion. 
     
     
         5 . The prosthetic capsular device of  claim 2 , wherein the prosthetic capsular device comprises a biologically-compatible material. 
     
     
         6 . The prosthetic capsular device of  claim 2 , wherein the prosthetic capsular device is deformable. 
     
     
         7 . The prosthetic capsular device of  claim 2 , wherein the prosthetic capsular device is foldable. 
     
     
         8 . The prosthetic capsular device of  claim 2 , wherein the prosthetic capsular device possesses sufficient elasticity to resume its pre-folded shape. 
     
     
         9 . The prosthetic capsular device of  claim 2 , wherein the prosthetic capsular device is self-expanding. 
     
     
         10 . The prosthetic capsular device of  claim 2 , wherein the prosthetic capsular device comprises an optically clear material. 
     
     
         11 . The prosthetic capsular device of  claim 2 , wherein the slow release fully or partially dissolvable pharmaceutical agent or non-dissolvable prostheses is located in a periphery of an interior of the housing structure. 
     
     
         12 . The prosthetic capsular device of  claim 2 , wherein the slow release fully or partially dissolvable pharmaceutical agent or non-dissolvable prostheses comprises a toroidal shape. 
     
     
         13 . A prosthetic capsular device configured to be inserted in a natural capsular bag of an eye after removal of a lens, the device comprising:
 a housing structure having a discoid shape configured to contain one or more intraocular lenses or technology devices, the housing structure comprising:
 a longitudinal axis; 
 a posterior side; 
 an anterior side opposite the posterior side, the anterior side comprising an anterior opening; 
 a continuous lateral side extending between the posterior side and the anterior side, the continuous lateral side comprising a protrusion projecting therefrom; 
 a cavity at least partially defined by the posterior side, the anterior side, and the continuous lateral side, wherein the anterior opening is configured to allow insertion of the one or more intraocular lenses or technology devices into the cavity of the housing structure through the anterior opening; 
 an exterior surface of the housing structure comprising a middle portion, wherein the exterior surface of the housing structure tapers radially inward from the middle portion to the anterior opening; and 
 an insulation structure that thermally insulates the eye from heat produced by the one or more technology devices contained in the cavity; and 
   a slow release fully or partially dissolvable pharmaceutical agent or a non-dissolvable prostheses coated with a slow release pharmaceutical agent for introduction into the eye, wherein the slow release fully or partially dissolvable pharmaceutical agent or non-dissolvable prostheses is located within the housing structure outside a visual axis of the eye.   
     
     
         14 . The prosthetic capsular device of  claim 13 , wherein the prosthetic capsular device comprises a biologically-compatible material. 
     
     
         15 . The prosthetic capsular device of  claim 13 , wherein the prosthetic capsular device is deformable. 
     
     
         16 . The prosthetic capsular device of  claim 13 , wherein the prosthetic capsular device is foldable. 
     
     
         17 . The prosthetic capsular device of  claim 13 , wherein the prosthetic capsular device possesses sufficient elasticity to resume its pre-folded shape. 
     
     
         18 . The prosthetic capsular device of  claim 13 , wherein the prosthetic capsular device is self-expanding. 
     
     
         19 . The prosthetic capsular device of  claim 13 , wherein the prosthetic capsular device comprises an optically clear material. 
     
     
         20 . The prosthetic capsular device of  claim 13 , wherein the slow release fully or partially dissolvable pharmaceutical agent or non-dissolvable prostheses is located in a periphery of an interior of the housing structure. 
     
     
         21 . The prosthetic capsular device of  claim 13 , wherein the slow release fully or partially dissolvable pharmaceutical agent or non-dissolvable prostheses comprises a toroidal shape.

Join the waitlist — get patent alerts

Track US2023181312A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.